NCT00486356: Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer |
|
|
| Completed | 1 | 46 | US | capecitabine, Xeloda, carboplatin, Paraplatin, epirubicin hydrochloride, Ellence, microarray analysis, polymorphism analysis, pharmacological study | University of Nebraska, National Cancer Institute (NCI) | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Gastric Cancer, Liver Cancer, Unspecified Adult Solid Tumor, Protocol Specific | 01/10 | 01/10 | | |
